APA

Ackermann M., Lachmann N., Hartung S., Eggenschwiler R., Pfaff N., Happle C., Mucci A., Göhring G., Niemann H., Hansen G., Schambach A., Cantz T., Zweigerdt R. & Moritz T. (20140819). Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. : Biomaterials.

Chicago

Ackermann Mania, Lachmann Nico, Hartung Susann, Eggenschwiler Reto, Pfaff Nils, Happle Christine, Mucci Adele, Göhring Gudrun, Niemann Heiner, Hansen Gesine, Schambach Axel, Cantz Tobias, Zweigerdt Robert and Moritz Thomas. 20140819. Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. : Biomaterials.

Harvard

Ackermann M., Lachmann N., Hartung S., Eggenschwiler R., Pfaff N., Happle C., Mucci A., Göhring G., Niemann H., Hansen G., Schambach A., Cantz T., Zweigerdt R. and Moritz T. (20140819). Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. : Biomaterials.

MLA

Ackermann Mania, Lachmann Nico, Hartung Susann, Eggenschwiler Reto, Pfaff Nils, Happle Christine, Mucci Adele, Göhring Gudrun, Niemann Heiner, Hansen Gesine, Schambach Axel, Cantz Tobias, Zweigerdt Robert and Moritz Thomas. Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. : Biomaterials. 20140819.